Steve L. Abrams

1.0k total citations
8 papers, 625 citations indexed

About

Steve L. Abrams is a scholar working on Molecular Biology, Organic Chemistry and Genetics. According to data from OpenAlex, Steve L. Abrams has authored 8 papers receiving a total of 625 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 2 papers in Organic Chemistry and 2 papers in Genetics. Recurrent topics in Steve L. Abrams's work include Hedgehog Signaling Pathway Studies (2 papers), Chronic Lymphocytic Leukemia Research (2 papers) and Wnt/β-catenin signaling in development and cancer (2 papers). Steve L. Abrams is often cited by papers focused on Hedgehog Signaling Pathway Studies (2 papers), Chronic Lymphocytic Leukemia Research (2 papers) and Wnt/β-catenin signaling in development and cancer (2 papers). Steve L. Abrams collaborates with scholars based in United States, Italy and Poland. Steve L. Abrams's co-authors include James A. McCubrey, Linda S. Steelman, Massimo Libra, Lucio Cocco, Alberto M. Martelli, Dariusz Rakus, Agnieszka Gizak, Giuseppe Montalto, Melchiorre Cervello and Ferdinando Nicoletti and has published in prestigious journals such as Blood, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research and Oncotarget.

In The Last Decade

Steve L. Abrams

8 papers receiving 621 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Steve L. Abrams United States 5 444 135 82 49 48 8 625
Melissa L. Sokolosky United States 6 521 1.2× 182 1.3× 121 1.5× 48 1.0× 52 1.1× 6 697
Taekwon Son South Korea 14 364 0.8× 142 1.1× 106 1.3× 33 0.7× 51 1.1× 26 576
Shuo Dong China 17 605 1.4× 141 1.0× 68 0.8× 34 0.7× 57 1.2× 27 786
Dimitri Lodygin Germany 8 560 1.3× 126 0.9× 87 1.1× 41 0.8× 40 0.8× 9 696
Merei Huigsloot Netherlands 15 455 1.0× 94 0.7× 80 1.0× 36 0.7× 76 1.6× 16 671
Monica Cubillos‐Rojas Spain 14 426 1.0× 131 1.0× 65 0.8× 37 0.8× 58 1.2× 25 611
Tatsuya Usui Japan 12 334 0.8× 111 0.8× 80 1.0× 20 0.4× 44 0.9× 19 506
Jun Zheng China 15 310 0.7× 109 0.8× 174 2.1× 36 0.7× 56 1.2× 45 593
Maria Teresa Rizzo United States 13 254 0.6× 128 0.9× 83 1.0× 35 0.7× 56 1.2× 40 601
Tetsuhiro Horie Japan 14 282 0.6× 132 1.0× 85 1.0× 28 0.6× 27 0.6× 37 459

Countries citing papers authored by Steve L. Abrams

Since Specialization
Citations

This map shows the geographic impact of Steve L. Abrams's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steve L. Abrams with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steve L. Abrams more than expected).

Fields of papers citing papers by Steve L. Abrams

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steve L. Abrams. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steve L. Abrams. The network helps show where Steve L. Abrams may publish in the future.

Co-authorship network of co-authors of Steve L. Abrams

This figure shows the co-authorship network connecting the top 25 collaborators of Steve L. Abrams. A scholar is included among the top collaborators of Steve L. Abrams based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steve L. Abrams. Steve L. Abrams is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
McCubrey, James A., Kvin Lertpiriyapong, Linda S. Steelman, et al.. (2017). Regulation of GSK-3 activity by curcumin, berberine and resveratrol: Potential effects on multiple diseases. Advances in Biological Regulation. 65. 77–88. 44 indexed citations
2.
Steelman, Linda S., Steve L. Abrams, Peter P. Ruvolo, et al.. (2017). Drug-resistance in doxorubicin-resistant FL5.12 hematopoietic cells: elevated MDR1, drug efflux and side-population positive and decreased BCL2-family member expression. Oncotarget. 8(68). 113013–113033. 7 indexed citations
3.
McCubrey, James A., Dariusz Rakus, Agnieszka Gizak, et al.. (2016). Effects of mutations in Wnt/β-catenin, hedgehog, Notch and PI3K pathways on GSK-3 activity—Diverse effects on cell growth, metabolism and cancer. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1863(12). 2942–2976. 131 indexed citations
4.
McCubrey, James A., Linda S. Steelman, Fred E. Bertrand, et al.. (2014). GSK-3 as potential target for therapeutic intervention in cancer. Oncotarget. 5(10). 2881–2911. 398 indexed citations
5.
6.
Abrams, Steve L., Camilla Evangelisti, Francesca Chiarini, et al.. (2007). Roles of Raf/MEK/ERK and PI3K/Akt/mTOR Pathways in Prevention of Apoptosis and Induction of Drug Resistance in Myeloid Hematopoietic Cells.. Blood. 110(11). 641–641. 1 indexed citations
7.
8.
Shelton, John G., Linda S. Steelman, Steve L. Abrams, et al.. (2005). The epidermal growth factor receptor gene family as a target for therapeutic intervention in numerous cancers: what’s genetics got to do with it?. Expert Opinion on Therapeutic Targets. 9(5). 1009–1030. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Melissa L. Sokolosky Breakdown of academic impact, for papers by Taekwon Son Breakdown of academic impact, for papers by Shuo Dong Breakdown of academic impact, for papers by Dimitri Lodygin Breakdown of academic impact, for papers by Merei Huigsloot Breakdown of academic impact, for papers by Monica Cubillos‐Rojas Breakdown of academic impact, for papers by Tatsuya Usui Breakdown of academic impact, for papers by Jun Zheng Breakdown of academic impact, for papers by Maria Teresa Rizzo Breakdown of academic impact, for papers by Tetsuhiro Horie
Rankless by CCL
2026